A machine-learning approach to finding treatment options for COVID-19
Researchers have developed a system to identify drugs that might be repurposed to fight the coronavirus in elderly patients
Researchers have developed a system to identify drugs that might be repurposed to fight the coronavirus in elderly patients
Increasing Portuguese market presence by enhancing sales and after-sales support networks
RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in viral entry, and is therefore expected to be effective against emerging viral variants with mutations in the spike protein
Inspired by decades-old MIT research, the new technology could boost quantum computers and other superconducting electronics.
AstraZeneca, Exactmer, Novartis and UK Research & Innovation aim to make the UK the first country in the world to deliver this pioneering production process at a large scale
Scripting services streamline automated liquid handler performance and user convenience
Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery process
The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus
New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific
The adjustable tip spacing pipettes from INTEGRA are used to increase efficiency in the production of venom-based screening assays
CryoLogyx will use research emerging from Professor Gibson’s laboratories to transform how cells, and cell-based therapies are stored and transported
RNA controls can help avoid false negative results
Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing